Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-47.14	12.43	-23.52
Graham Fair Price	-57.39	841.72	1975.43
PEG	2065.01	0.04	< 0.005
Price/Book	-18.60	1.18	1.45
Price/Cash Flow	18.41	-9.37	-11.49
Prices/Earnings	-432.06	-3.65	-0.69
Price/Sales	-38.81	1.58	2.59
Price/FCF	18.41	-9.37	-11.49
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	546.06	0.26	-0.04
Operating Margin	70.09	-0.09	-0.31
ROA	85.39	-0.03	-0.21
ROE	-0.53	-0.08	84.70
ROIC	-0.08	-0.03	64.35
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.10	0.24	-60.56
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.82	0.61	-25.96
EPS QOQ	-3.39	0.83	-75.42
FCF QOQ	-3.55	0.02	-99.41
Revenue QOQ	-0.13	0.31	133.18
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	54.57	59.63	9.28
Days Sales Outstanding (DSO)	74.78	60.06	-19.69
Inventory Turnover	1.65	1.51	-8.49
Debt/Capitalization	0.57	0.60	5.86
Quick Ratio	0.46	0.47	1.40
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	573.78	625.06	8.94
Cash	232.40	287.18	23.57
Capex	-9.65	-4.20	56.54
Free Cash Flow	-72.23	-78.51	-8.69
Revenue	320.97	465.15	44.92
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.70	0.70	1.07
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-10.30	6.41	-37.79
Naive Interpretation	Member

06 - Financial Health · Bad

Rating